S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
AMEX
Asterias Biotherapeutics Common Series A (AST)
Asterias Biotherapeutics Common Series A (AST) News

AST

Asterias Biotherapeutics, Inc. (AST)

Asterias Biotherapeutics Common Series A

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:AST

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
03/20/2019	4:07PM	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/20/2019	5:02AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/20/2019	5:02AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/20/2019	5:01AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/14/2019	1:55PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/14/2019	1:55PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/14/2019	1:53PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/14/2019	1:52PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/14/2019	1:50PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/14/2019	1:49PM	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/14/2019	1:48PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/12/2019	4:00PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/12/2019	3:52PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/12/2019	5:06AM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/08/2019	3:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/08/2019	2:18PM	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	AMEX:AST	Asterias Biotherapeutics Common Series A
03/05/2019	3:35PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/05/2019	3:33PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/05/2019	3:33PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/01/2019	3:35PM	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:AST	Asterias Biotherapeutics Common Series A
03/01/2019	3:34PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
02/28/2019	4:24PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
02/04/2019	4:26PM	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	AMEX:AST	Asterias Biotherapeutics Common Series A
01/24/2019	3:01PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
01/24/2019	6:00AM	GlobeNewswire Inc.	Asterias Provides Top Line 12 Month Data Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury	AMEX:AST	Asterias Biotherapeutics Common Series A
01/04/2019	4:13PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
01/04/2019	4:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:AST	Asterias Biotherapeutics Common Series A
01/04/2019	7:00AM	GlobeNewswire Inc.	BioTime Announces Management Changes Concurrent With Participation at 2019 J.P. Morgan Healthcare Conference and 2019 Biotech...	AMEX:AST	Asterias Biotherapeutics Common Series A
12/06/2018	5:22AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A
12/06/2018	5:17AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	AMEX:AST	Asterias Biotherapeutics Common Series A

Showing the most relevant articles for your search:AMEX:AST

1 2 3 4 5 6 7 8 9 10 Next >>

Silver Mountain Mines

Beacon Minerals

Antler Gold (PK)

MGLUV225 Ex:2,24

MOURA DUBEAUX ON

Leonteq Securities

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions